Literature DB >> 27156793

Analytical performance evaluation of Anyplex II HPV28 and Euroarray HPV for genotyping of cervical samples.

Ardashel Latsuzbaia1, Jessica Tapp2, Trung Nguyen2, Marc Fischer3, Marc Arbyn4, Steven Weyers5, Joël Mossong2.   

Abstract

Analytically accurate human papillomavirus (HPV) genotyping methods are required to assess the impact of HPV vaccination. The aim of this study was to evaluate the analytical performance of Anyplex II HPV28 (Seegene, Korea) and Euroarray HPV (Euroimmun, Germany) genotyping kits, for conducting a future HPV vaccine efficacy monitoring study in Luxembourg. A total number of 150 cervical swabs were collected from women with mean age 31.4 years. Agreements for detecting any HPV between Aptima/Anyplex (88.0%) and Aptima/Euroarray (90.7%) were similar. Agreement of Anyplex/EuroArray with Aptima was higher for Genotypes 16, 18 or 45 than for the other 11 HPVs. The average number of HPV genotypes detected per sample was similar with 2.6 and 2.5, for Anyplex and EuroArray, respectively. In conclusion, Anyplex and Euroarray showed high agreement in general and in particular for detecting genotypes contained in HPV vaccines.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anyplex II HPV28; Euroarray HPV; HPV genotyping; Human papilloma virus; Method comparison; Vaccine monitoring

Mesh：

Year:  2016        PMID： 27156793     DOI： 10.1016/j.diagmicrobio.2016.04.011

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  13 in total

1.  Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities.

Authors:  A M Cornall; M Poljak; S M Garland; S Phillips; J H Tan; D A Machalek; M A Quinn; S N Tabrizi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-08       Impact factor: 3.267

2.  Comparison of Seegene Anyplex II HPV28 assay with BD Onclarity HPV assay for human papillomavirus genotyping.

Authors:  Moonsik Kim; Jinhee Kim; Nora Jee-Young Park; Ji Young Park
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

3.  Human papillomavirus genotype concordance between Anyplex II HPV28 and linear array HPV genotyping test in anogenital samples.

Authors:  François Coutlée; Alexandra de Pokomandy; Ann N Burchell; Mariam El-Zein; Marie-Hélène Mayrand; Sophie Rodrigues-Coutlée; Deborah Money; Émilie Comète; Elisabeth McClymont; Danielle Rouleau; Eduardo L Franco
Journal:  J Med Virol       Date:  2022-01-28       Impact factor: 20.693

4.  HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples.

Authors:  Alyssa M Cornall; Marin Poljak; Suzanne M Garland; Samuel Phillips; Dorothy A Machalek; Jeffrey H Tan; Michael A Quinn; Sepehr N Tabrizi
Journal:  Papillomavirus Res       Date:  2017-10-18

5.  Unusual and unique distribution of anal high-risk human papillomavirus (HR-HPV) among men who have sex with men living in the Central African Republic.

Authors:  Ralph-Sydney Mboumba Bouassa; Marcel Mbeko Simaleko; Serge Police Camengo; Christian Diamant Mossoro-Kpinde; David Veyer; Mathieu Matta; Leman Robin; Jean De Dieu Longo; Gérard Grésenguet; Hélène Péré; Jean-François Meye; Laurent Belec
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

6.  The receptor for activated protein kinase C promotes cell growth, invasion and migration in cervical cancer.

Authors:  Shan Liao; Songshu Xiao; Hongxiang Chen; Manying Zhang; Zhifang Chen; Yuehua Long; Lu Gao; Junyu He; Yanshan Ge; Wei Yi; Minghua Wu; Guiyuan Li; Yanhong Zhou
Journal:  Int J Oncol       Date:  2017-09-27       Impact factor: 5.650

7.  Presence of multiple genotypes in subjects with HPV-16 infection is highly associated with anal squamous intraepithelial lesions in HIV-1 infected males.

Authors:  Cristina Rovelli; Andrea Poli; Laura Galli; Massimo Cernuschi; Andrea Marco Tamburini; Sara Racca; Giuseppe Tambussi; Serena Rolla; Luca Albarello; Riccardo Rosati; Adriano Lazzarin; Antonella Castagna; Silvia Nozza
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

8.  High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N'Djamena, Chad.

Authors:  Ralph-Sydney Mboumba Bouassa; Zita Aleyo Nodjikouambaye; Damtheou Sadjoli; Chatté Adawaye; Hélène Péré; David Veyer; Mathieu Matta; Leman Robin; Serge Tonen-Wolyec; Ali Mahamat Moussa; Donato Koyalta; Laurent Belec
Journal:  PLoS One       Date:  2019-06-03       Impact factor: 3.240

9.  Clinical performance of Anyplex II HPV28 by human papillomavirus type and viral load in a referral population.

Authors:  Ingrid Baasland; Pål R Romundstad; Maj Liv Eide; Christine M Jonassen
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

10.  Molecular epidemiology and socio-demographic risk factors of sexually transmitted infections among women in Lebanon.

Authors:  Jessica Hanna; Ruba Yassine; Rana El-Bikai; Martin D Curran; Mathilde Azar; Joumana Yeretzian; Rana Skaf; Claude Afif; Toufic Saber; Saadeddine Itani; Manal Hubeish; Tamima El Jisr; Fadia Hamzeh; Mira El Chaar
Journal:  BMC Infect Dis       Date:  2020-05-27       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.